Neuropathological classification of Huntington's disease
- PMID: 2932539
- DOI: 10.1097/00005072-198511000-00003
Neuropathological classification of Huntington's disease
Abstract
In postmortem brain specimens from 163 clinically diagnosed cases of Huntington's disease (HD) the striatum exhibited marked variation in the severity of neuropathological involvement. A system for grading this severity was established by macroscopic and microscopic criteria, resulting in five grades (0-4) designated in ascending order of severity. The grade correlates closely with the extent of clinical disability as assessed by a rating scale. In five cases of clinically diagnosed HD there were no discernible neuropathological abnormalities (grade 0), suggesting that the anatomical changes lag behind the development of clinical abnormalities. In eight cases, neuropathological changes could only be recognized microscopically (grade 1). The earliest changes were seen in the medial paraventricular portions of the caudate nucleus (CN), in the tail of the CN, and in the dorsal part of the putamen. Counts of neurons in the CN reveal that 50% are lost in grade 1 and that 95% are lost in grade 4; astrocytes are greatly increased in grades 2-4. These studies indicate that analyses of the CN in grade 4 would reflect mainly its astrocytic composition with a component of remote neurons projecting to the striatum. Because of the relative preservation of the lateral half of the head of the CN in grades 1-2, these regions would reflect early cellular and biochemical changes in HD.
Similar articles
-
Compartmental loss of NADPH diaphorase in the neuropil of the human striatum in Huntington's disease.Neuroscience. 1993 Mar;53(1):159-68. doi: 10.1016/0306-4522(93)90294-p. Neuroscience. 1993. PMID: 7682296
-
The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease.Neuroscience. 2000;97(3):505-19. doi: 10.1016/s0306-4522(00)00008-7. Neuroscience. 2000. PMID: 10828533
-
Decreased neuronal and increased oligodendroglial densities in Huntington's disease caudate nucleus.J Neuropathol Exp Neurol. 1991 Nov;50(6):729-42. doi: 10.1097/00005072-199111000-00005. J Neuropathol Exp Neurol. 1991. PMID: 1836225
-
The neuropathological features of neuroacanthocytosis.Mov Disord. 1994 May;9(3):297-304. doi: 10.1002/mds.870090303. Mov Disord. 1994. PMID: 8041370 Review.
-
The selective vulnerability of striatopallidal neurons.Prog Neurobiol. 1999 Dec;59(6):691-719. doi: 10.1016/s0301-0082(99)00019-2. Prog Neurobiol. 1999. PMID: 10845758 Review.
Cited by
-
Signaling Pathways Concerning Mitochondrial Dysfunction: Implications in Neurodegeneration and Possible Molecular Targets.J Mol Neurosci. 2024 Oct 28;74(4):101. doi: 10.1007/s12031-024-02269-5. J Mol Neurosci. 2024. PMID: 39466510 Review.
-
Systematic interaction network filtering identifies CRMP1 as a novel suppressor of huntingtin misfolding and neurotoxicity.Genome Res. 2015 May;25(5):701-13. doi: 10.1101/gr.182444.114. Genome Res. 2015. PMID: 25908449 Free PMC article.
-
Genetic manipulations of mutant huntingtin in mice: new insights into Huntington's disease pathogenesis.FEBS J. 2013 Sep;280(18):4382-94. doi: 10.1111/febs.12418. Epub 2013 Jul 31. FEBS J. 2013. PMID: 23829302 Free PMC article. Review.
-
Chromosome substitution strain assessment of a Huntington's disease modifier locus.Mamm Genome. 2015 Apr;26(3-4):119-30. doi: 10.1007/s00335-014-9552-9. Epub 2015 Feb 3. Mamm Genome. 2015. PMID: 25645993 Free PMC article.
-
Making (anti-) sense out of huntingtin levels in Huntington disease.Mol Neurodegener. 2015 Apr 28;10:21. doi: 10.1186/s13024-015-0018-7. Mol Neurodegener. 2015. PMID: 25928884 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical